SCHEMBL13601635

SCHEMBL13601635

CC1CCN(C(=O)CCC(=O)OCCN2CCOCC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
POLB P06746 1/20 0.55
TSHR P16473 1/20 0.55
ALDH1A1 P00352 6/20 0.53
HRH3 Q9Y5N1 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
GLA P06280 1/20 0.42
ATM Q13315 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
TNF P01375 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601637 0.93 HRH3 (0.54) LMNAPOLBTSHRALDH1A1HRH3
SCHEMBL12881504 0.88 LMNA (0.52) LMNAPOLBTSHRALDH1A1HRH3
SCHEMBL13601670 0.85 TSHR (0.58) LMNAPOLBTSHRALDH1A1HRH3
SCHEMBL12881512 0.84 LMNA (0.49) LMNAPOLBTSHRALDH1A1HRH3
SCHEMBL8262848 0.82 HRH3 (0.50) LMNAPOLBTSHRALDH1A1HRH3
SCHEMBL12881519 0.82 TSHR (0.49) LMNAPOLBTSHRALDH1A1HRH3
SCHEMBL12881500 0.81 LMNA (0.50) LMNAPOLBTSHRALDH1A1HRH3
SCHEMBL2606050 0.80 NPC1 (0.67) LMNAPOLBTSHRALDH1A1NPC1
SCHEMBL13601626 0.79 NPC1 (0.57) LMNAPOLBTSHRALDH1A1NPC1
SCHEMBL13601424 0.79 HRH3 (0.53) LMNAPOLBALDH1A1HRH3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed